The Challenges Manufacturers and Notified Bodies Face in Light of the Changing Regulatory Requirements in the EU
Andreas F. Stange, PhD, Vice President MHS Global IVD, TÜV SÜD, Germany
Premier Sponsors
Programs
6 May Advances in Prenatal Molecular Diagnostics
7-8 May Biomarkers for Immunotherapy
Advanced Diagnostics for Infectious Disease
Enabling Technologies for Circulating Biomarkers
8-9 May Companion Diagnostics for Immuno-Oncology
Point-of-Care Diagnostics
Clinical Applications of Circulating Biomarkers
Short Courses